BioCentury

7:00 AM GMT, May 8, 2000
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Status

105AD7: Began Phase I/II testing

Onyvax Ltd., London, U.K.
Product: 105AD7
Business: Cancer
Therapeutic

Read the full 93 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.